DelMar Pharmaceuticals, Inc. 4/A
4/A · DelMar Pharmaceuticals, Inc. · Filed Oct 31, 2014
Insider Transaction Report
Form 4/AAmended
Garner William J
Director
Transactions
- Conversion
Exchangeable Shares
2014-03-18−80,000→ 2,438,541 total(indirect: See Footnote)→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]Exchangeable Shares are shares of Exchangeco (as that term is defined in the Issuer's Current Report on Form 8-K filed with the SEC on January 31, 2013) which are exchangeable on a 1-for-1 basis for shares of common stock in the Issuer at any time at the discretion of the Reporting Person. This Form 4/A amends the Form 4 filed by the Reporting Person on March 20, 2014 solely to amend the disclosure of the Exchangeable Shares beneficially owned as of such date by the Reporting Person.
- [F2]Shares are held in trust by Jeffrey Bacha.